ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 95 filers reported holding ONCOCYTE CORP in Q2 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $28,000 | -62.2% | 38,291 | -53.4% | 0.00% | – |
| Q2 2022 | $74,000 | -79.8% | 82,096 | -66.6% | 0.00% | – |
| Q1 2022 | $366,000 | -48.5% | 245,850 | -24.8% | 0.00% | -100.0% |
| Q4 2021 | $710,000 | -2.6% | 327,090 | +59.8% | 0.00% | 0.0% |
| Q3 2021 | $729,000 | +243.9% | 204,627 | +455.2% | 0.00% | – |
| Q2 2021 | $212,000 | – | 36,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $61,766,000 | 3.15% |
| Defender Capital, LLC. | 1,960,820 | $6,935,000 | 2.26% |
| Millrace Asset Group, Inc. | 613,885 | $2,185,000 | 1.36% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $43,517,000 | 1.32% |
| Penbrook Management LLC | 577,200 | $2,055,000 | 1.28% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $1,175,000 | 0.61% |
| AWM Investment Company, Inc. | 717,000 | $2,553,000 | 0.25% |
| Colonial River Wealth Management, LLC | 66,200 | $218,000 | 0.15% |
| CALIBER WEALTH MANAGEMENT, LLC | 66,200 | $218,000 | 0.15% |
| Fort Sheridan Advisors LLC | 110,000 | $392,000 | 0.13% |